CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 556 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00222404
NCT00222404N/ACompleted
CompareCT.gov

Pharmacogenomic Study Realized Within the Framework of the Common Care to "Non-small Cell Lung Carcinoma" at Any Stages Treated by Chemotherapy.

University Hospital, Grenoble·observational·Posted Sep 22, 2005·Updated Nov 5, 2010

In Brief

An observational study for Carcinoma, Non-Small-Cell Lung. Completed, enrolled 556 participants across 1 site.

Detailed Summary

The purpose of this study is to correlate molecular genetic profile with response to chemotherapy in case of primary chemotherapy treatment for non-small cells lung carcinoma.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCarcinoma, Non-Small-Cell Lung
CountriesFrance
CollaboratorsMinistry of Health, France

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 22, 2005
Enrollment StartJul 1, 2005
Study CompletionAug 1, 2010
TodayJul 2, 2026
Posted 20.8 years ago